Will Amgen say “Imfinzi / Durvalumab”?
Amgen said “Imfinzi / Durvalumab” 5 times on its Nov 3, 2026 call (FY26 Q3), and on 2 of its last 8 calls: 0, 1, 0, 0, 0, 0, 0, 5 times. As of Nov 11, 2026, Amgen said “Imfinzi / Durvalumab” on the only call with a settled Kalshi mention market so far, on Nov 3, 2026. Parrot’s p for the next listing is 59% (n=1, from settlement history blended with transcripts), not a forecast.
- Last 10
- 1/1Last 10 settled, oldest to newest: yes
- Streak
- said last time
- Counts
- company speakers + operator
- Market
- 41¢ Kalshi (may be delayed)
Where it was said
quotes of at most 25 words; select an appearanceAmgen
Imfinzi / Durvalumab
- Probability
- 59% · n=1
- Settled
- 1/1 (100%)
- Last calls
- said in 2 of 8
Next listing counts: company speakers + operator
Counts: company speakers + operator
5 counted (5 in prepared remarks, 0 in Q&A).
…phase III results from the DeLLphi-305 study evaluating IMDELLTRA in combination with IMFINZI in first-line maintenance treatment. I was at the European Society for Medical…
…practice-changing results for IMDELLTRA from the DeLLphi-305 study that evaluates IMDELLTRA plus IMFINZI versus IMFINZI alone as first-line maintenance treatment. The combination of IMDELLTRA into…
Counts: company speakers + operator (not listed here; the usual rule)
1 counted (1 in prepared remarks, 0 in Q&A).
…stage small cell lung cancer, here in combination with carboplatin, etoposide and durvalumab. We also continue to investigate our CD19 directed BiTE medicine BLINCYTO in…
Every settled listing
newest first · 1 shown| Date | Listed as | Venue | Result | Our count |
|---|---|---|---|---|
| Nov 3, 2026 | Imfinzi / Durvalumab |  Kalshi | Yes | 5 |
Questions
- How many times did Amgen say “Imfinzi / Durvalumab” on its last earnings call?
- Amgen said “Imfinzi / Durvalumab” 5 times on its Nov 3, 2026 call (FY26 Q3), and on 2 of its last 8 calls: 0, 1, 0, 0, 0, 0, 0, 5 times.
- How often does Amgen say “Imfinzi / Durvalumab”?
- As of Nov 11, 2026, Amgen said “Imfinzi / Durvalumab” on the only call with a settled Kalshi mention market so far, on Nov 3, 2026.
- What is the probability Amgen says “Imfinzi / Durvalumab” next time?
- 59%, from settlement history blended with transcripts (n=1). It is a base rate from history, not a forecast and not advice.
- Who has to say it for the market to count?
- Under the next market's rule: company speakers + operator.
Cite parrot.markets, “Amgen: ‘Imfinzi / Durvalumab’ mention history”, as of Nov 11, 2026, https://parrot.markets/earnings/AMGN/words/durvalumab-or-imfinzi (CC BY 4.0)
Agents: this page as TSV at /api/v1/word?entity=amgen&word=durvalumab%20%2F%20imfinzi · quotes: /api/v1/quotes?entity=amgen&word=… · columnar JSON in #parrot-data · llms.txt · MCP